Recent trends in treatment admissions for prescription opioid abuse during pregnancy

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 37-42

  Martin, Caitlin E ^a   Longinaker, Nyaradzo ^b   Terplan, Mishka ^c  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Opioids; Pregnancy; Prescription opioids; Substance abuse; Substance abuse treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; OPIATE;

ADULT; ALCOHOLISM; ARTICLE; CAUCASIAN; COCAINE DEPENDENCE; CRIMINAL JUSTICE; DEMOGRAPHY; DRUG DEPENDENCE TREATMENT; DRUG MISUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; OPIATE ADDICTION; PREGNANCY; PRIORITY JOURNAL; UNITED STATES; COMORBIDITY; OPIOID-RELATED DISORDERS; PREGNANCY COMPLICATIONS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; COMORBIDITY; FEMALE; HUMANS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRESCRIPTION DRUG MISUSE; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES; YOUNG ADULT;

EID: 84922782273     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.007     Document Type: Article

References (35)

1. ACOG Committee on Health Care for Underserved Women, & American Society of Addiction Medicine ACOG committee opinion no. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology 2012, 119(5):1070-1076. 10.1097/AOG.0b013e318256496e.
2. Azadi A., Dildy G.A. Universal screening for substance abuse at the time of parturition. American Journal of Obstetrics and Gynecology 2008, 198(5):e30-e32. 10.1016/j.ajog.2007.10.780.
3. Behnke M., Smith V.C., Committee on Substance Abuse, Committee on fetus, newborn Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics 2013, 131(3):e1009-e1024. 10.1542/peds.2012-3931.
4. Centers for Disease Control and Prevention (CDC) Vital signs: Overdoses of prescription opioid pain relievers--United States, 1999-2008. MMWR. Morbidity and Mortality Weekly Report 2011, 60(43):1487-1492.
5. Centers for Disease Control and Prevention (CDC) Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR. Morbidity and Mortality Weekly Report 2013, 62(26):537-542.
6. Creanga A.A., Sabel J.C., Ko J.Y., Wasserman C.R., Shapiro-Mendoza C.K., Taylor P., et al. Maternal drug use and its effect on neonates: A population-based study in Washington State. Obstetrics and Gynecology 2012, 119(5):924-933. 10.1097/AOG.0b013e31824ea276.
7. Environmental Systems Resource Institute ArcMap 10.2 2013, (Redlands, CA).
8. Fox K., Merrill J.C., Chang H.H., Califano J.A. Estimating the costs of substance abuse to the Medicaid hospital care program. American Journal of Public Health 1995, 85(1):48-54.
9. Fullerton C.A., Kim M., Thomas C.P., Lyman D.R., Montejano L.B., Dougherty R.H., et al. Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services (Washington, D.C.) 2014, 65(2):146-157. 10.1176/appi.ps.201300235.
10. Hardt N., Wong T.D., Burt M.J., Harrison R., Winter W., Roth J. Prevalence of prescription and illicit drugs in pregnancy-associated non-natural deaths of Florida mothers, 1999-2005. Journal of Forensic Sciences 2013, 10.1111/1556-4029.12219.
11. Hudak M.L., Tan R.C., Committee on Drugs, Committee on fetus and newborn, American Academy of Pediatrics Neonatal drug withdrawal. Pediatrics 2012, 129(2):e540-e560. 10.1542/peds.2011-3212.
12. Jones H.E., Finnegan L.P., Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012, 72(6):747-757. 10.2165/11632820-000000000-00000.
13. Jones H.E., O'Grady K.E., Malfi D., Tuten M. Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 2008, 17(5):372-386. 10.1080/10550490802266276.
14. Kaltenbach K., Finnegan L. Prevention and treatment issues for pregnant cocaine-dependent women and their infants. Annals of the New York Academy of Sciences 1998, 846:329-334.
15. Kellogg A., Rose C.H., Harms R.H., Watson W.J. Current trends in narcotic use in pregnancy and neonatal outcomes. American Journal of Obstetrics and Gynecology 2011, 204(3):259.e1-259.e4. 10.1016/j.ajog.2010.12.050.
16. Kellogg A., Rose C.H., Harms R.H., Watson W.J. Current trends in narcotic use in pregnancy and neonatal outcomes. American Journal of Obstetrics and Gynecology 2011, 204(3):259.e1-259.e4. 10.1016/j.ajog.2010.12.050.
17. Martin, C. E., Mak, C., Miller, C., Welsh, C., & Terplan, M. (In press). Trends in drug-exposed deliveries from 2002 to 2009. Addictive Disorders & their Treatment 2014.
18. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Database of Systematic Reviews 2009, (3):CD002209. 10.1002/14651858.CD002209.pub2.
19. McCabe J.E., Arndt S. Demographic and substance abuse trends among pregnant and non-pregnant women: Eleven years of treatment admission data. Maternal and Child Health Journal 2012, 16(8):1696-1702. 10.1007/s10995-011-0872-z.
20. McDonald D.C., Carlson K., Izrael D. Geographic variation in opioid prescribing in the U.S. The Journal of Pain: Official Journal of the American Pain Society 2012, 13(10):988-996. 10.1016/j.jpain.2012.07.007.
21. Muhuri P.K., Gfroerer J.C. Substance use among women: Associations with pregnancy, parenting, and race/ethnicity. Maternal and Child Health Journal 2009, 13(3):376-385. 10.1007/s10995-008-0375-8.
22. Newman R.G., Bashkow S., Calko D. Results of 313 consecutive live births of infants delivered to patients in the New York City methadone maintenance treatment program. American Journal of Obstetrics and Gynecology 1975, 121(2):233-237.
23. Pan I.J., Yi H.Y. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008. Maternal and Child Health Journal 2013, 17(4):667-676. 10.1007/s10995-012-1046-3.
24. Patrick S.W., Schumacher R.E., Benneyworth B.D., Krans E.E., McAllister J.M., Davis M.M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA: The Journal of the American Medical Association 2012, 307(18):1934-1940. 10.1001/jama.2012.3951.
25. Rigg K.K., March S.J., Inciardi J.A. Prescription drug abuse & diversion: Role of the pain clinic. Journal of Drug Issues 2010, 40(3):681-702.
26. StataCorp Stata statistical software: Release 12 2011, StataCorp LP, College Station, TX.
27. Substance Abuse and Mental Health Services Administration 1996 National survey on drug abuse: Preliminary results. (No. (SMA) 97-3149) 1997, (Rockville, MD).
28. Substance Abuse and Mental Health Services Administration Results from the 2002 national survey on drug use and health: Summary of national findings. (No. HHS Publication No. SMA 03-3836) 2003.
29. Substance Abuse and Mental Health Services Administration Results from the 2010 national survey on drug use and health: Summary of national findings. (No. HHS Publication No. (SMA) 11-4658) 2011.
30. Substance Abuse and Mental Health Services Administration Results from the 2012 national survey on drug use and health: Summary of national findings, NSDUH series H-46. (No. HHS (SMA) 13-4795) 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
31. Substance Abuse and Mental Health Services Administration (SAMHSA) Treatment episode data set (TEDS) 1992-2010 2013, (Retrieved 01/20, 2014, Retrieved from http://wwwdasis.samhsa.gov/dasis2/teds.htm).
32. Substance Abuse and Mental Health Services Administration (SAMHSA) Trends in the use of methadone and buprenorphine at substance abuse treatment facilities: 2003 to 2011. 2013.
33. Terplan M., Smith E.J., Glavin S.H. Trends in injection drug use among pregnant women admitted into drug treatment: 1994-2006. Journal of Women's Health 2010, 19(3):499-505. (2002). 10.1089/jwh.2009.1562.
34. Terplan M., Smith E.J., Kozloski M.J., Pollack H.A. Methamphetamine use among pregnant women. Obstetrics and Gynecology 2009, 113(6):1285-1291. 10.1097/AOG.0b013e3181a5ec6f.
35. Winklbaur-Hausknost B., Jagsch R., Graf-Rohrmeister K., Unger A., Baewert A., Langer M., et al. Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Human Psychopharmacology 2013, 28(1):15-24. 10.1002/hup.2275.